Overview
- Health authorities confirmed the country’s first mpox death in mid-November, a Rio de Janeiro resident who had a preexisting immunosuppressive condition.
- National monitoring shows more than 1,000 confirmed mpox cases in 2026 with notifications accelerating since October and October–early November accounting for a large share of new diagnoses.
- Cases are concentrated mainly in Rio de Janeiro and São Paulo, with Rio reporting several hundred infections in 2026 and most municipal cases clustered in the capital.
- State laboratories have detected MPXV subtype 1b in multiple localities, prompting stepped-up genomic surveillance to track whether this lineage is driving transmission or severity changes.
- The Ministry of Health purchased 25,000 vaccine doses with delivery expected in about three weeks and states have begun targeted two-dose vaccination for defined high-risk groups under a 28-day interval.